Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S,R,S)-AHPC-PEG2-C4-Cl is a small molecule HaloPROTAC, comprising the (S,R,S)-AHPC based VHL ligand and a 2-unit PEG linker, that induces the degradation of GFP-HaloTag7 in cell-based assays[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $61 | 5 days | |
5 mg | $98 | Backorder |
Description | (S,R,S)-AHPC-PEG2-C4-Cl is a small molecule HaloPROTAC, comprising the (S,R,S)-AHPC based VHL ligand and a 2-unit PEG linker, that induces the degradation of GFP-HaloTag7 in cell-based assays[1]. |
In vitro | (S,R,S)-AHPC-PEG2-C4-Cl employs the VHL ligand to facilitate the development of PROTACs targeting the oncogenic tyrosine kinase BCR-ABL, using a 6-2-2 linker that balances hydrophobicity and hydrophilicity. This compound can conjugate with potent tyrosine kinase inhibitors (TKIs) like bosutinib and dasatinib to promote the degradation of c-ABL and BCR-ABL via CRBN or VHL E3 ubiquitin ligase mechanisms. |
Alias | VHL Ligand-Linker Conjugates 7, VH032-PEG2-C4-Cl, E3 ligase Ligand-Linker Conjugates 10 |
Molecular Weight | 651.26 |
Formula | C32H47ClN4O6S |
Cas No. | 1835705-57-1 |
Relative Density. | 1.218 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (76.77 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.